2023 Q2 Form 10-Q Financial Statement

#000140658723000086 Filed on April 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $368.9M $301.5M
YoY Change 19.58% -28.49%
Cost Of Revenue $283.9M $245.6M
YoY Change 21.01% -26.49%
Gross Profit $85.00M $55.90M
YoY Change 15.02% -36.11%
Gross Profit Margin 23.04% 18.54%
Selling, General & Admin $26.40M $22.00M
YoY Change 9.54% -9.47%
% of Gross Profit 31.06% 39.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $800.0K $800.0K
YoY Change 14.29% 60.0%
% of Gross Profit 0.94% 1.43%
Operating Expenses $26.40M $22.00M
YoY Change 9.54% -9.47%
Operating Profit $58.60M $33.90M
YoY Change 17.67% -46.36%
Interest Expense $3.800M $2.000M
YoY Change 1800.0%
% of Operating Profit 6.48% 5.9%
Other Income/Expense, Net
YoY Change
Pretax Income $62.40M $35.90M
YoY Change 18.41% -43.2%
Income Tax $15.60M $9.000M
% Of Pretax Income 25.0% 25.07%
Net Earnings $46.80M $26.90M
YoY Change 17.88% -43.72%
Net Earnings / Revenue 12.69% 8.92%
Basic Earnings Per Share $0.94 $0.54
Diluted Earnings Per Share $0.93 $0.54
COMMON SHARES
Basic Shares Outstanding 49.90M shares 49.77M shares
Diluted Shares Outstanding 50.18M shares 50.01M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $401.0M $286.7M
YoY Change 174.09% 22.68%
Cash & Equivalents $401.0M $286.7M
Short-Term Investments
Other Short-Term Assets $18.20M $16.80M
YoY Change -28.63% 64.71%
Inventory
Prepaid Expenses
Receivables $24.60M $19.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $443.8M $286.7M
YoY Change 137.71% 17.4%
LONG-TERM ASSETS
Property, Plant & Equipment $1.922B $1.994B
YoY Change 34840.0% 39772.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $500.0K $500.0K
YoY Change 25.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $1.932B $2.050B
YoY Change -7.18% 3.13%
TOTAL ASSETS
Total Short-Term Assets $443.8M $286.7M
Total Long-Term Assets $1.932B $2.050B
Total Assets $2.375B $2.336B
YoY Change 4.74% 4.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $68.60M $67.70M
YoY Change 7.52% 21.76%
Accrued Expenses $120.5M $147.2M
YoY Change -16.26% -6.84%
Deferred Revenue $7.500M $11.40M
YoY Change -55.88% -35.59%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $322.6M $345.0M
YoY Change -12.0% -6.81%
LONG-TERM LIABILITIES
Long-Term Debt $707.2M $706.8M
YoY Change 0.23% 0.21%
Other Long-Term Liabilities $15.00M $18.40M
YoY Change -32.13% -28.4%
Total Long-Term Liabilities $722.2M $706.8M
YoY Change -0.76% -3.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $322.6M $345.0M
Total Long-Term Liabilities $722.2M $706.8M
Total Liabilities $1.080B $1.089B
YoY Change -3.57% -3.18%
SHAREHOLDERS EQUITY
Retained Earnings $602.4M $555.6M
YoY Change 31.79% 33.11%
Common Stock $693.1M $692.2M
YoY Change 0.48% 0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.296B $1.248B
YoY Change
Total Liabilities & Shareholders Equity $2.375B $2.336B
YoY Change 4.74% 4.69%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $46.80M $26.90M
YoY Change 17.88% -43.72%
Depreciation, Depletion And Amortization $800.0K $800.0K
YoY Change 14.29% 60.0%
Cash From Operating Activities $114.9M $71.10M
YoY Change -232.37% 0.42%
INVESTING ACTIVITIES
Capital Expenditures $500.0K $200.0K
YoY Change -171.43% -120.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$500.0K -$200.0K
YoY Change -16.67% -80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K -600.0K
YoY Change -142.86%
NET CHANGE
Cash From Operating Activities 114.9M 71.10M
Cash From Investing Activities -500.0K -200.0K
Cash From Financing Activities -100.0K -600.0K
Net Change In Cash 114.3M 70.30M
YoY Change -230.78% -1.26%
FREE CASH FLOW
Cash From Operating Activities $114.9M $71.10M
Capital Expenditures $500.0K $200.0K
Free Cash Flow $114.4M $70.90M
YoY Change -232.87% -1.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001406587
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2022Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33662
dei Entity Registrant Name
EntityRegistrantName
FORESTAR GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1336998
dei Entity Address Address Line1
EntityAddressAddressLine1
2221 E. Lamar Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 790
dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76006
dei City Area Code
CityAreaCode
817
dei Local Phone Number
LocalPhoneNumber
769-1860
dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
dei Trading Symbol
TradingSymbol
FOR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49897709 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
286700000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264800000 usd
CY2023Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1988000000 usd
CY2022Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
2022400000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
500000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
500000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5600000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5700000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
55500000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
49600000 usd
CY2023Q1 us-gaap Assets
Assets
2336300000 usd
CY2022Q3 us-gaap Assets
Assets
2343000000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
67700000 usd
CY2022Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
72200000 usd
CY2023Q1 for Accrued Development Costs
AccruedDevelopmentCosts
99100000 usd
CY2022Q3 for Accrued Development Costs
AccruedDevelopmentCosts
122300000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
130100000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
136200000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35700000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
36900000 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
48100000 usd
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
70100000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
706800000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
706000000.0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1087500000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1143700000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49897709 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49761480 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
49900000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
49800000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
642300000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
640600000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
555600000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
507900000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1247800000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1198300000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
1000000.0 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
1000000.0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1248800000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1199300000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2336300000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2343000000 usd
CY2023Q1 us-gaap Revenues
Revenues
301500000 usd
CY2022Q1 us-gaap Revenues
Revenues
421600000 usd
us-gaap Revenues
Revenues
518200000 usd
us-gaap Revenues
Revenues
829200000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
245600000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
334100000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
414800000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
668300000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22000000.0 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24300000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44900000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45800000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1100000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1600000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
500000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2000000.0 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
3700000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35900000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63200000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116700000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000000.0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15400000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28400000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
26900000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
47800000 usd
us-gaap Profit Loss
ProfitLoss
47700000 usd
us-gaap Profit Loss
ProfitLoss
88300000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26900000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
47800000 usd
us-gaap Net Income Loss
NetIncomeLoss
47700000 usd
us-gaap Net Income Loss
NetIncomeLoss
88300000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49900000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49800000 shares
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1199300000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
20800000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
600000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1220600000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
26900000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
700000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1900000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1248800000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1015900000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
40500000 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
84547 shares
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1700000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
400000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1058400000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
47800000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
400000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1600000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1107400000 usd
us-gaap Profit Loss
ProfitLoss
47700000 usd
us-gaap Profit Loss
ProfitLoss
88300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1200000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1400000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2500000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2000000.0 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
22700000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
6000000.0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1600000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
500000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9600000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
61100000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3000000.0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3800000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26500000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29400000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-23200000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16100000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7200000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76600000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
300000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2500000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12500000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1500000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
1600000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
3200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1300000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2200000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1700000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
700000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21900000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80100000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264800000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153600000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16100000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233700000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
10400000 usd
CY2023Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1988000000 usd
CY2022Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
2022400000 usd
us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
47200000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
374400000 usd
CY2023Q1 for Real Estate Carrying Value
RealEstateCarryingValue
35500000 usd
us-gaap Inventory Write Down
InventoryWriteDown
19400000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3800000 usd
CY2023Q1 for Due Diligence Write Offs
DueDiligenceWriteOffs
900000 usd
for Due Diligence Write Offs
DueDiligenceWriteOffs
3300000 usd
CY2022Q1 for Due Diligence Write Offs
DueDiligenceWriteOffs
1600000 usd
for Due Diligence Write Offs
DueDiligenceWriteOffs
2200000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
10100000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7500000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12500000 usd
CY2023Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
41100000 usd
CY2022Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
100000 usd
us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
44400000 usd
us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
3600000 usd
CY2023Q1 us-gaap Revenues
Revenues
301500000 usd
CY2022Q1 us-gaap Revenues
Revenues
421600000 usd
us-gaap Revenues
Revenues
518200000 usd
us-gaap Revenues
Revenues
829200000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7500000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
55700000 usd
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
52900000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
52500000 usd
CY2021Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
53700000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
8200000 usd
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
8100000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
16400000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
16300000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
5100000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
19400000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
58800000 usd
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
50600000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
58800000 usd
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
50600000 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
19100000 usd
CY2022Q3 us-gaap Other Receivables
OtherReceivables
11400000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7500000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7500000 usd
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
16800000 usd
CY2022Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
18900000 usd
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
7300000 usd
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
10000000.0 usd
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
1200000 usd
CY2022Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
0 usd
CY2023Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
3600000 usd
CY2022Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
1800000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
55500000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
49600000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
6400000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
11600000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
2800000 usd
CY2022Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
6200000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8100000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8100000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6700000 usd
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8000000.0 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11400000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16100000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
4100000 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
4100000 usd
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1200000 usd
CY2022Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
8200000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
4500000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
6800000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
2900000 usd
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1000000.0 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
48100000 usd
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
70100000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
706800000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
706000000.0 usd
CY2023Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
410000000 usd
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
600000000 usd
CY2023Q1 for Letterof Credit Maximum Borrowing Capacity
LetterofCreditMaximumBorrowingCapacity
100000000 usd
CY2023Q1 for Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment
LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment
0.50
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
42600000 usd
CY2023Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
367400000 usd
CY2020Q2 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 usd
CY2023Q1 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50010539 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49878166 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49954781 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26900000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
47800000 usd
us-gaap Net Income Loss
NetIncomeLoss
47700000 usd
us-gaap Net Income Loss
NetIncomeLoss
88300000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49943373 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49820937 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49916927 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49752153 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
67166 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
57229 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
37854 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
53364 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49805517 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15400000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28400000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2023Q1 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
-34800000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
900000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35700000 usd
CY2022Q3 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
-35900000 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1000000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
36900000 usd
CY2021Q4 for Equity Securities Registered Value
EquitySecuritiesRegisteredValue
750000000 usd
CY2021Q4 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
300000000 usd
for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
0 shares
CY2023Q1 for Common Stock Availablefor Issuance Value Remaining
CommonStockAvailableforIssuanceValueRemaining
748200000 usd
CY2023Q1 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
298200000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
512545 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.76
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1900000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2500000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2000000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
42600000 usd
CY2023Q1 us-gaap Special Assessment Bond
SpecialAssessmentBond
635100000 usd
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
7300000 usd
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
293500000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
900000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1400000 usd
CY2023Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
57800 lot
CY2022Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
61800 lot
CY2023Q1 for Numberof Lots Sold
NumberofLotsSold
2979 lot
CY2022Q1 for Numberof Lots Sold
NumberofLotsSold
5788 lot
for Numberof Lots Sold
NumberofLotsSold
5242 lot
for Numberof Lots Sold
NumberofLotsSold
10304 lot
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
286700000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
706800000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264800000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
706000000.0 usd

Files In Submission

Name View Source Status
0001406587-23-000086-index-headers.html Edgar Link pending
0001406587-23-000086-index.html Edgar Link pending
0001406587-23-000086.txt Edgar Link pending
0001406587-23-000086-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
for-20230331.htm Edgar Link pending
for-20230331.xsd Edgar Link pending
for-20230331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
for-20230331_def.xml Edgar Link unprocessable
for-20230331_pre.xml Edgar Link unprocessable
for-20230331_lab.xml Edgar Link unprocessable
for-20230331_htm.xml Edgar Link completed
for-20230331_cal.xml Edgar Link unprocessable